temporal arteritis

(redirected from giant cell arteritis)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.temporal arteritis - inflammation of the temporal arteries; characterized by headaches and difficulty chewing and (sometimes) visual impairment
arteritis - inflammation of an artery
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in ?
References in periodicals archive ?
Role of the CCR5/32CCR5 polymorphism in biopsy-proven giant cell arteritis. Hum Immunol.
A Giant cell arteritis (GCA--also called temporal arteritis) is a condition characterized by inflammation of the linings of larger blood vessels, usually in the head and very often in the region of the temples.
Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
* identify patients who are failing or are likely to fail conventional therapy for giant cell arteritis, and institute appropriate alternative treatments.
Systemic signs or symptoms could suggest a metabolic or systemic inflammatory disease, such as giant cell arteritis.
Food and Drug Administration has approved ACTPen 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra as an additional formulation for adult patients with moderate to severe active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs, and for adult patients with giant cell arteritis. Further, the ACTPen can be administered by caregivers to patients two years of age and older with active polyarticular juvenile idiopathic arthritis or active systemic juvenile idiopathic arthritis.
M2 PHARMA-July 27, 2017-Genentech Publishes Positive Results Actemra (Tocilizumab) for the Treatment of Giant Cell Arteritis
M2 EQUITYBITES-May 23, 2017-US FDA approves first drug Actemra for treating giant cell arteritis
The medical history was significant for temporal giant cell arteritis (GCA) two years earlier, which remained in remission after nine months of corticosteroids.